blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3539374

EP3539374 - NON-HUMAN ANIMALS EXPRESSING PH-SENSITIVE IMMUNOGLOBULIN SEQUENCES [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  12.02.2021
Database last updated on 03.09.2024
FormerRequest for examination was made
Status updated on  20.03.2020
FormerThe application has been published
Status updated on  16.08.2019
Most recent event   Tooltip26.07.2024New entry: Reply to examination report 
Applicant(s)For all designated states
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
[2019/38]
Inventor(s)01 / MCWHIRTER, John
c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
02 / MACDONALD, Lynn
c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
03 / MARTIN, Joel, H
c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
04 / MURPHY, Andrew, J
c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
 [2019/38]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2019/38]J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date19156973.015.03.2013
[2019/38]
Priority number, dateUS201261611950P16.03.2012         Original published format: US 201261611950 P
US201261612126P16.03.2012         Original published format: US 201261612126 P
US201261613352P20.03.2012         Original published format: US 201261613352 P
US201261736930P13.12.2012         Original published format: US 201261736930 P
[2019/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3539374
Date:18.09.2019
Language:EN
[2019/38]
Search report(s)(Supplementary) European search report - dispatched on:EP24.06.2019
ClassificationIPC:A01K67/027, C07K16/00, C12N15/85
[2019/38]
CPC:
A01K67/0278 (EP,CN,IL,KR,RU,US); A01K67/0275 (IL,RU,US); C07K16/00 (EP,CN,IL,KR,US);
C12N15/8509 (EP,CN,IL,RU,US); A01K2217/072 (EP,CN,IL,KR,US); A01K2217/075 (EP,CN,IL,KR,US);
A01K2217/15 (EP,CN,IL,KR,US); A01K2227/105 (EP,CN,IL,KR,US); A01K2267/01 (EP,CN,IL,KR,US);
C07K2317/10 (EP,CN,IL,US); C07K2317/21 (EP,CN,IL,KR,US); C07K2317/565 (IL,KR);
C07K2317/92 (EP,CN,IL,KR,US); C07K2317/94 (EP,CN,IL,KR,US); C12N2800/204 (EP,CN,IL,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/17]
Former [2019/38]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:NICHT-MENSCHLICHE TIERE ZUR EXPRESSION PH-SENSITIVER IMMUNOGLOBULINSEQUENZEN[2019/38]
English:NON-HUMAN ANIMALS EXPRESSING PH-SENSITIVE IMMUNOGLOBULIN SEQUENCES[2019/38]
French:ANIMAUX NON HUMAINS EXPRIMANT DES SÉQUENCES D'IMMUNOGLOBULINE SENSIBLES AU PH[2019/38]
Examination procedure18.03.2020Amendment by applicant (claims and/or description)
18.03.2020Examination requested  [2020/17]
18.03.2020Date on which the examining division has become responsible
12.02.2021Despatch of a communication from the examining division (Time limit: M04)
14.06.2021Reply to a communication from the examining division
07.11.2022Despatch of a communication from the examining division (Time limit: M04)
17.03.2023Reply to a communication from the examining division
27.03.2024Despatch of a communication from the examining division (Time limit: M04)
25.07.2024Reply to a communication from the examining division
Parent application(s)   TooltipEP13714127.1  / EP2825037
Fees paidRenewal fee
13.02.2019Renewal fee patent year 03
13.02.2019Renewal fee patent year 04
13.02.2019Renewal fee patent year 05
13.02.2019Renewal fee patent year 06
13.02.2019Renewal fee patent year 07
20.03.2020Renewal fee patent year 08
23.03.2021Renewal fee patent year 09
23.03.2022Renewal fee patent year 10
21.03.2023Renewal fee patent year 11
20.03.2024Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US2006015957  (LONBERG NILS [US], et al);
 [A]EP2275443  (CHUGAI PHARMACEUTICAL CO LTD [JP]);
 [A]WO2011097603  (REGENERON PHARMA [US], et al);
 [A]WO2011111007  (RINAT NEUROSCIENCE CORP [US], et al);
by applicantUS5599908
 US5603931
 US6586251
 US6596541
 US6774279
 US7105348
 US7294754
 US2007280945
 US2008078000
 US7576259
 US7659442
 US2010331527
 US2011111406
 US2011195454
 US2012021409
 US2012192300
 US2012192309
 US2012322108
 US2013045492
 US20100832838
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.